Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Patent
1988-01-12
1990-01-16
Rollins, John W.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
514317, 514408, 514569, 514649, 514731, 514874, 514899, A61K 31535, A61K 31445, A61K 3140, A61K 3119
Patent
active
048943738
ABSTRACT:
Disclosed is a method for treating menopausal symptoms and treating and preventing osteoporosis, wherein a true antiestrogen is administered and estrogen is not. This treatment is effective for female osteoporosis and can also be used to treat male osteoporosis. Examples of true antiestrogens are clomiphene, and its isomers, citrates and derivatives, as well as several other compounds which appear in the specification.
REFERENCES:
patent: 4820736 (1989-04-01), Jensen et al.
Endocrinol. Japon., vol. 23, No. 2, 1976, pp. 115-118.
T. Hashimoto et al.: "Dual Effect of Clomiphene Citrate on Pituitary Gonadotropin Secretion in Postmenopausal Women", *Whole Article*.
J. Clin. Endocrinol. Metab., vol. 42, No. 3, 1976, pp. 593-594.
T. Hashimoto et al.: "Effect of Clomiphene Citrate on Basal and LHR-Induced Gonadotropin Secretion in Postmenopausal Women", *Whole Article*.
Neuroendocrinol. Lett., vol. 4, No. 6, 1982, pp. 377-381, Verlag Chemie GmbH, Weinheim, DE.
J. A. Moguilevsky et al.: "Effect of Clomiphene Citrate on LH, FSH and Estradiol Levels in Postmenopausal Women", *Whole Article*.
Ann. Endocrinol., vol. 38, No. 6, 1977, pp. 363-365, Paris, FR M. Pugeat et al.: "Effects du Citrate de Clomiphene et des Oestrogenes sur les Taux Plasmatiques des Gonadotrophines, Testosterone, Androstenedione Chez les Femmes Agees Menopausees", *Summary*.
Munchener Med. Wochenschrift, vol. 112, No. 51, 18th Dec. 1970, pp. 2303--2312, Munich, DE.
P. Franchimont: "Gonadotropin-Sekretion beim Menschen", *p. 2307*.
Martindale, The Extra Pharmacopoeia, 28th Edition, 1982, p. 140, Edited by J. E. F. Reynolds, The Pharmaceutical Press, London, GB *Monograph 9037-9039*.
Z. Artzl. Fortbild. (Jena), vol. 68, No. 15, 1974, pp. 796-801, W. Mobius: "Die Moderne Behandlung Klimakterischer Beschwerden", *p. 800, right-hand column, lines 4-8*.
Drug & Therapeutics Bulletin, vol. 16, No. 4, 17th Feb. 1978, pp. 13-16, "Management of the Menopause", *p. 14, last paragraph*.
Cah Med. Lyon, vol. 50, nr. 14, 1974, pp. 1227-1229, G. Tanne: "Le praticien devant . . . la menopause", *p. 1228*.
Acta Obstet. Gynec. Scand., vol. 54, No. Suppl. 51, 1975, pp. 47-61, Ch. Lauritzen: "The Female Climacteric Syndrome: Significance, Problems, Treatment:", *p. 52, right-hand column, p. 53, table 5*.
Vie Med. Can. Fr., vol. 7, No. 3, 1978, pp. 217-223, Y. Ainmelk: "Pharmacotherapie de la Menopause", *p. 221*.
Concours Med., vol. 98, No. 8 Suppl. 1976, pp. 1-48.
J. A. Mahoudeau et al.: "Pathologie ovarienne", *p. 22*.
Beall et al, Calcif. Tissue Int'l. 36: 123-125, 1984.
Chem. Abst. 100:132789g, 1984.
BCM Technologies, Inc.
Conley Ned L.
Mirabel Eric P.
Rollins John W.
Rose David A.
LandOfFree
Antiestrogens and their use in treatment of menopause and osteop does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Antiestrogens and their use in treatment of menopause and osteop, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Antiestrogens and their use in treatment of menopause and osteop will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1334990